CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 119 enrolled
Drug / intervention
Nu Femme +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02269891
NCT02269891Phase 2Completed
CompareCT.gov

A Randomized Double-Blind, Placebo-Controlled, Parallel Clinical Trial on the Efficacy of a Combination Herbal Product, Biotropics' Nu Femme, on Menopausal Symptoms and Quality of Life in Women

KGK Science Inc.·interventional·Posted Oct 21, 2014·Updated Nov 13, 2018

In Brief

A Phase 2 clinical trial evaluating Nu Femme and Placebo for Menopausal Symptoms. Completed, enrolled 119 participants across 4 sites.

Detailed Summary

The purpose of this study is to assess the effectiveness of an herbal combination product called Nu Femme, on menopausal symptoms in peri-menopausal women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenopausal Symptoms
CountriesCanada
CollaboratorsBiotropics Malaysia Berhad

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 21, 2014
Enrollment StartOct 1, 2014
Primary CompletionSep 27, 2018
TodayJul 1, 2026
Enrollment to primary: 4.0 yearsPosted 11.7 years ago

Interventions

Nu Femmedietary

Combination product of Labisia pumila and Eurycoma longifolia extracts

Placeboother